Levofloxacin Pf Rafarm

Levofloxacin, the active ingredient in Levofloxacin Pf Rafarm, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. It targets bacterial pathogens responsible for eye infections and is indicated for adult patients with bacterial conjunctivitis, keratitis, and other ocular bacterial infections.

GNH USA supplies Levofloxacin Pf Rafarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, providing reliable access to quality‑assured ophthalmic antibiotics for patient care. The company adheres to stringent quality standards and offers logistical support for global distribution.

Levofloxacin ophthalmic solution is a fluoroquinolone antibiotic used to treat bacterial infections of the eye. - Bacterial conjunctivitis: eliminates the causative bacteria, leading to rapid reduction of redness, tearing, and discharge. - Bacterial keratitis: penetrates corneal tissue to eradicate bacterial pathogens, supporting corneal epithelial recovery and preventing scarring. - Other ocular bacterial infections: provides broad‑spectrum antibacterial activity against susceptible organisms, helping to restore ocular comfort and visual clarity.

Levofloxacin ophthalmic solution may cause ocular and systemic adverse reactions.

Common Side Effects: - Eye irritation: transient burning or stinging upon instillation. - Redness: mild conjunctival hyperemia. - Foreign body sensation: feeling of grit in the eye. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Tendon rupture: rare systemic tendon injury. - Severe allergic reaction: angioedema or anaphylaxis. - Corneal ulceration: worsening of corneal integrity. - Vision loss: rare but serious visual impairment.

Before prescribing Levofloxacin ophthalmic solution, clinicians should consider several precautionary measures. - Allergy assessment: avoid use in patients with known hypersensitivity to fluoroquinolones. - Corneal disease: use cautiously in patients with pre‑existing corneal ulceration or epithelial defects. - Systemic fluoroquinolone exposure: monitor for additive tendon toxicity if patient receives systemic fluoroquinolones. - Pregnancy and lactation: prescribe only if potential benefit justifies potential risk, as safety data are limited. - Pediatric use: limit to patients over a certain age as per local guidelines. - Store at room temperature: keep in original container, protect from light and moisture.

Levofloxacin ophthalmic solution can interact with other medications, influencing efficacy or safety.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase risk of tendon rupture. - Anticholinergic eye drops: may reduce ocular absorption of levofloxacin. - Corticosteroid eye preparations: may mask signs of infection.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): monitor for delayed wound healing. - Herbal supplements containing quinine: may potentiate QT prolongation risk. - Vitamin C eye drops: may affect drug stability.